Status:
COMPLETED
Folinic Acid in Autism
Lead Sponsor:
University of California, San Francisco
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
5-25 years
Phase:
PHASE2
PHASE3
Brief Summary
An examination of changes in urinary metabolites with use of folinic acid in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures and academic measures mon...
Detailed Description
Children enrolled in Oak Hill School will enroll in this study and take folinic acid supplement twice a day for 12 weeks period. Behavioral measures and urinary metabolites will be collected pre and p...
Eligibility Criteria
Inclusion
- Between ages 5 and 25
Exclusion
- Not currently taking folinic acid
Key Trial Info
Start Date :
February 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03771560
Start Date
February 15 2018
End Date
June 30 2018
Last Update
December 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143